Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

18.67
Delayed Data
As of May 02
 -0.51 / -2.66%
Today’s Change
16.91
Today|||52-Week Range
62.90
-53.46%
Year-to-Date

Today’s Trading

Previous close19.18
Today’s open19.23
Day’s range17.91 - 19.23
Volume1,070,893
Average volume (3 months)1,097,334
Market cap$702.8M
Dividend yield--
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)+149.38%
Earnings growth (this year)-21.04%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+48.60%
P/E ratio6.0
Price/Sales5.42
Price/Book1.50

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.25+1.22%
SCLNSciClone Pharmaceuti...+0.53+4.02%
INSMInsmed Inc+0.30+2.47%
SRPTSarepta Therapeutics...+3.73+26.29%
Data as of 05/02/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)$0.62
Annual revenue (last year)$406.8M
Annual profit (last year)$149.9M
Net profit margin36.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
President &
Chief Operating Officer
Michael J. Bogda
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

Partner Offers

Search for Jobs